In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 199 for your search:
Drug:  imatinib mesylate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571AUS177, US177, RIGHT Trial, NCT00081926

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 20 to 74
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571BJP07, NCT00171977

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571BDE28, 2005-001537-15, NCT00372476

4.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571BDE59, 2006-000218-19, NCT00427999

5.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571ACA09, NCT00171899

6.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAMN107FJP01, NCT01043874

7.

Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: CSTI571ADE75T, 2010-018339-16, NCT01243489

8.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT 2010-019189-94, NCT01297777

9.

Phase: Phase IV
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ISAV, 2011-002749-37, NCT01578213

10.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAMN107DCN03, NCT01613053

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CDR0000068089, NOVARTIS-CSTI5710106, FHCRC-1556.00, NCT00006343

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02372, INT-S0033, S0033, CDR0000068422, CAN-NCIC-S0033, SWOG-S0033, CLB-80004, E-S0033, U10CA032102, N01CM17003, NCT00009906

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: NCI-2012-01862, CDR0000068859, COG-AALL0031, AALL0031, U10CA098543, NCT00022737

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02930, Z9001, CDR0000069452, U10CA076001, ACOSOG-Z9001, CAN-NCIC-SRC1, CALGB-ACOSOG-Z9001, SWOG-ACOSOG-Z9001, UWCC-UW-6303, UWCC-UW-03-8438-A-03, SRC1, NCT00041197

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000078099, E2993, MRC-LEUK-UKALL-XII, EST-4491, ECOG-2993, INT-0132, NCT00002514

16.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: III-MK-CML-IV, EU-20248, NCT00055874

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-62024, ISG-62024, FRE-FNCLCC-EORTC-62024, GEIS-EORTC-62024, 2004-001810-16, EUDRACT-2004-001810-16, NCT00103168

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SSGXVIII/AIO, NCT00116935

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 030482, NCT00219739

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571BDE40, NCT00154375

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CECOG/GIST 1.2.001, CSTI571BIC07, NCT00293124

22.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00776, S0502, CDR0000482236, U10CA032102, SWOG-S0502, CALGB-S0502, CAN-NCIC-S0502, NCT00324987

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CST1571BFR14, ET2002-021, NCT00367861

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAMN107A2303, 2007-000208-34, NCT00471497

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA180-056, 2006-005712-27, NCT00481247
1     
New Search